Daniel Delaney, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 123 W Germantown Pike, Suite 2, East Norriton, PA 19401 Phone: 610-278-7456 Fax: 610-278-7457 |
Courtney B. Hartmann, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 559 W Germantown Pike, East Norriton, PA 19403 Phone: 215-456-7000 |
Lori Jo Yakish, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 559 W Germantown Pike, East Norriton, PA 19403 Phone: 215-456-6850 Fax: 215-254-2599 |
Rose Obrien, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 559 W Germantown Pike, East Norriton, PA 19403 Phone: 215-456-6850 Fax: 215-254-2599 |
Mark Anthony Cane, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 559 W Germantown Pike, East Norriton, PA 19403 Phone: 484-622-1000 |
News Archive
In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine found that the asthma medication montelukast (brand name Singulair) can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, in a mouse model of type 1 diabetes.
Bausch & Lomb today announced that the company's Lo-Torque- lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
Artificial implants such as pacemakers often cause complications because the body identifies them as foreign objects. Researchers at ETH Zurich have now demonstrated a simple method to fabricate cellulose-sheaths for implants, whose micro-structured surface makes them especially biocompatible.
A new study suggests that less than 10% of the estimated 3,591 adults in the UK with the genetic condition congenital adrenal hyperplasia (CAH) receive specialist endocrine care, and that there is no standard treatment for these patients.
Results of two clinical trials reported at the American Society for Clinical Oncology Annual Meeting 2015 show continued promise of immune therapies nivolumab and pembrolizumab against advanced melanomas, specifically in the context of PD1 signaling that some tumors use to avoid immune system attack. Dr. Rene Gonzalez, MD, investigator at the University of Colorado Cancer Center and director of the Melanoma Research Clinics at the CU School of Health, is an author of both studies.
› Verified 3 days ago